Moleculin Biotech (MBRX) Q2 2023 Earnings

11AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.3
-0.27
-0.23
-0.2

Details

Expected EPS
-0.27
Actual EPS
-0.2
Surprise EPS
0.07
Surprise Percent
+25.93%

Description

Moleculin Biotech (MBRX) has reported earnings of -0.2 per share for Q2 2023.

0 Comments

Share your thoughts